Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic

Cancer

Volumn 113, Issue 6, 2008, Pages 1362-1369

  Morimoto, Akira ^a   Imamura, Toshihiko ^a   Ishii, Rumiko ^a   Nakabayashi, Yoshinobu ^b   Nakatani, Takuya ^a   Sakagami, Junichi ^a   Yamagami, Takuji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO FIRST RED CROSS HOSPITAL   (Japan)

Author keywords

Continuous regional arterial infusion; L asparaginase; Leukemia; Lymphoma; Pancreatitis

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GABEXATE MESILATE; IMIPENEM; METHOTREXATE; NAFAMSTAT MESILATE; OCTREOTIDE; PIRARUBICIN; PREDNISOLONE; PROTEINASE INHIBITOR; ULINASTATIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; HUMAN; LEUKEMIA; LYMPHOBLASTOMA; MALE; PANCREATITIS; PRIORITY JOURNAL; PSEUDOCYST;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; NEOPLASM RECURRENCE, LOCAL; PANCREATIC PSEUDOCYST; PANCREATITIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEASE INHIBITORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 53149154844     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23716     Document Type: Article

References (37)

1. Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol. 2007;61:208-221.
2. Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood. 2007; 109:896-904.
3. Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol. 2007;25:813-819.
4. Rowe JM, Buck G, Burnett AK, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005;106:3760-3767.
5. Sahu S, Saika S, Pai SK, Advani SH. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1998;15:533-538.
6. Alvarez OA, Zimmerman G. Pegaspargase-induced pancreatitis. Med Pediatr Oncol. 2000;34:200-205.
7. Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2007; 49:634-639.
8. Duval M, Suciu S, Ferster A, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organization for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood. 2002;99:2734-2739.
9. Avramis VI, Sencer S, Periclou AP, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002;99:1986-1994.
10. Winter SS, Holdsworth MT, Devidas M, et al. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Pediatr Blood Cancer. 2006;46:179-186.
11. Ronghe M, Burke GA, Lowis SP, Estlin EJ. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines. Cancer Treat Rev. 2001;27:327-337.
12. Beger HG, Rau BM. Severe acute pancreatitis: clinical course and management. World J Gastroenterol. 2007; 13:5043-5051.
13. Takeda K, Matsuno S, Sunamura M, Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg. 1996;171:394-398.
14. Takeda K, Matsuno S, Ogawa M, Watanabe S, Atomi Y. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. J Hepatobiliary Pancreat Surg. 2001;8:216-220.
15. Imaizumi H, Kida M, Nishimaki H, et al. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas. 2004;28:369-373.
16. Yasuda T, Ueda T, Takeyama Y, et al. Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis. J Gastroenterol. 2007;42:681-689.
17. Takeda K, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:42-47.
18. Morimoto A, Kuriyama K, Hibi S, et al. Prognostic value of early response to treatment combined with conventional risk factors in pediatric acute lymphoblastic leukemia. Int J Hematol. 2005;81:228-234.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
20. Ogawa M, Hirota M, Hayakawa T, et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas. 2002;25:325-330.
21. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology. 2002;223:603-613.
22. Sunamura M, Lozonschi L, Takeda K, Kobari M, Matsuno S. Criteria for diagnosis of acute pancreatitis in Japan and clinical implications. Pancreas. 1998;16:243-249.
23. Mayumi T, Ura H, Arata S, et al. Evidence-based clinical practice guidelines for acute pancreatitis: proposals. J Hepatobiliary Pancreat Surg. 2002;9:413-422.
24. Makela JT, Eila H, Kiviniemi H, Laurila J, Laitinen S. Computed tomography severity index and C-reactive protein values predicting mortality in emergency and intensive care units for patients with severe acute pancreatitis. Am J Surg. 2007;1194:30-34.
25. Chen CH, Lu MY, Lin KH, Lin DT, Peng SF, Jou ST. Ureteral obstruction caused by L-asparaginase-induced pancreatitis in a child with acute lymphoblastic leukemia. J Formos Med Assoc. 2004;103:380-384.
26. Lamelas RG, Chapchap P, Magalhaes AC, Filho JO, Mendes WL, de Camargo B. Successful management of a child with asparaginase-induced hemorrhagic pancreatitis [letter]. Med Pediatr Oncol. 1999;32:316.
27. Garrington T, Bensard D, Ingram JD, Silliman CC. Successful management with octreotide of a child with L-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol. 1998;30:106-109.
28. Yu CH, Lin KH, Lin DT, Chen RL, Horng YC, Chang MH. L-asparaginase- related pancreatic pseudocyst: report of a case. J Formos Med Assoc. 1994;93:441-444.
29. Yang CM, Hsieh YL, Hwang B. Acute pancreatitis in association with L-asparaginase therapy: report of 1 case. Zhonghua Yi Xue Za Zhi (Taipei). 1993;51:74-77.
30. Sadoff J, Hwang S, Rosenfeld D, Ettinger L, Spigland N. Surgical pancreatic complications induced by L-asparaginase. J Pediatr Surg. 1997;32:860-863.
31. Top PC, Tissing WJ, Kuiper JW, Pieters R, van Eijck CH. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Pediatr Blood Cancer. 2005;44:95-97.
32. Karabulut R, Sonmez K, Afsarlar C, Turkyilmaz Z, Can Basaklar A, Kale N. Pancreas pseudocyst associated with L-asparaginase treatment: a case report. Acta Chir Belg. 2005;105:667-669.
33. Murakawa M, Okamura T, Shibuya T, Harada M, Otsuka T, Niho Y. Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation. Ann Hematol. 1992;64:249-252.
34. Caniano DA, Browne AF, Boles ET Jr. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia. J Pediatr Surg. 1985;20:452-455.
35. Tiao MM, Chuang JH, Ko SF, Kuo HW, Liang CD, Chen CL. Pancreatitis in children: clinical analysis of 61 cases in southern Taiwan. Chang Gung Med J. 2002;25: 162-168.
36. Kitagawa M, Hayakawa T. Antiproteases in the treatment of acute pancreatitis. JOP. 2007;8(4 suppl):518-525.
37. Satoh H, Harada M, Tashiro S, Shiroya T, Imawaka H, Machii K. The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis. J Med Invest. 2004;51:186-193.